Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome von Legendre, C.M, Licht, C, Muus, P, Greenbaum, L.A, Babu, S, Bedrosian, C, Bingham, C, Cohen, D.J, Delmas, Y, Douglas, K, Eitner, F, Feldkamp, T, Fouque, D, Furman, R.R, Gaber, O, Herthelius, M, Hourmant, M, Karpman, D, Lebranchu, Y, Mariat, C, Menne, J, Moulin, B, Nürnberger, J, Ogawa, M, Remuzzi, G, Richard, T, Sberro-Soussan, R, Severino, B, Sheerin, N.S, Trivelli, A, Zimmerhackl, L.B, Goodship, T, Loirat, C

Volltext

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity von Cheng, S, Ma, J, Guo, A, Lu, P, Leonard, J P, Coleman, M, Liu, M, Buggy, J J, Furman, R R, Wang, Y L

Volltext

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors von Thompson, C.A., Charlson, M.E., Schenkein, E., Wells, M.T., Furman, R.R., Elstrom, R., Ruan, J., Martin, P., Leonard, J.P.

Volltext

Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia von Ghia, P, Coutre, S.E, Furman, R.R, Sharman, J.P, Cheson, B.D, Pagel, J.M, Hillmen, P, Barrientos, J.C, Zelenetz, A.D, Kipps, T.J, Flinn, I.W, Eradat, H.A, Lamanna, N, Coiffier, B, Pettitt, A, Li, X, Jahn, T.M, O'Brien, S.M, Hallek, M.J

Volltext

9205 Pralatrexate treatment response by key baseline parameters in the pivotal, multi-center, phase 2 study in relapsed or refractory peripheral T-cell lymphoma (PROPEL) von O'Connor, O, Coiffier, B, Zinzani, P.L, Pinter-Brown, L, Popplewell, L, Shustov, A, Furman, R.R, Borghaei, H, Roark, S, Horwitz, S.M

Volltext

S1634 A PHASE I FIRST‐IN‐HUMAN CLINICAL TRIAL OF CD19‐TARGETED 19–28Z/4–1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMAT... von Palomba, M.L., Batlevi, C., Riviere, I., Senechal, B., Wang, X., Yang, J., Kane, P., Bernal, Y., Furman, R.R., Diamonte, C., Halton, E., Pineda, J., Renier, B., Sadelain, M., Jae, P.

Volltext

PS1148 PRELIMINARY RESULTS OF A PHASE 1B/2 DOSE‐ESCALATION AND COHORT‐EXPANSION STUDY OF THE NONCOVALENT, REVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR (BTKI), VECABRUTINIB, IN B‐C... von Allan, J.N., Patel, K., Mato, A.R., Wierda, W.G., Pinilla‐Ibarz, J., Choi, M.Y., O’Brien, S.M., Davids, M.S., Pagel, J.M., Ward, R., Acton, G., Taverna, P., Fox, J.A., Furman, R.R., Brown, J.R.

Volltext

EFFECT OF SINGLE‐AGENT IBRUTINIB ON TUMOR DEBULKING AND REDUCTIONS IN TUMOR LYSIS SYNDROME (TLS) RISK IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) von Tam, C.S., Byrd, J.C., O'Brien, S., Coutre, S., Barr, P.M., Furman, R.R., Kipps, T.J., Burger, J.A., Stevens, D., Sharman, J., Ghia, P., Flinn, I., Zhou, C., Ninomoto, J., James, D.F., Wierda, W.G.

Volltext

LONG‐TERM EFFICACY AND SAFETY IN THE RESONATE STUDY: IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH UP TO FOUR YEARS FOLLOW‐UP von Montillo, M., Byrd, J.C., Hillmen, P., O'Brien, S., Barrientos, J.C., Reddy, N.M., Coutre, S., Tam, C.S., Mulligan, S.P., Jaeger, U., Barr, P.M., Furman, R.R., Kipps, T.J., Thornton, P., Moreno, C., Pagel, J.M., Burger, J.A., Jones, J., Dai, S., Vezan, R., James, D.F., Brown, J.R.

Volltext

New monoclonal antibodies for non-Hodgkin's lymphoma von Leonard, J. P., Martin, P., Ruan, J., Elstrom, R., Barrientos, J., Coleman, M., Furman, R. R.

Volltext

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL von Brown, J.R, Hillmen, Peter, O'Brien, S, Barrientos, J.C, Reddy, N.M, Coutre, S.E, Tam, Constantine S, Mulligan, S.P, Jaeger, U, Barr, P.M, Furman, R.R, Kipps, Thomas J, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, Marco, DeVos, S, Moreno, Carol, Pagel, J.M, Munir, Talha, Burger, Jan A, Chung, D, Lin, J, Gau, L, Chang, Betty, Cole, G, Hsu, E, James, D.F, Byrd, John C, Universitat Autònoma de Barcelona

Volltext bestellen

Informed consent von Freeman, R.R.

Volltext

A Practical Implementation of Silicon Microchannel Coolers for High Power Chips von Colgan, E.G., Furman, B., Gaynes, M., Graham, W.S., LaBianca, N.C., Magerlein, J.H., Polastre, R.J., Rothwell, M.B., Bezama, R.J., Choudhary, R., Marston, K.C., Toy, H., Wakil, J., Zitz, J.A., Schmidt, R.R.

Volltext

A New Symbolic Language for Diagramming Pacemaker/Heart Interaction von BROWNLEE, R.R., SHIMMEL-GOLDEN, J.B., DEL MARCO, C.J., FURMAN, S.

Volltext